<p>Nanosonics Limited ( (AU:NAN) ) 发布了更新。</p>
<p>Nanosonics Limited 宣布将于 2025 年召开年度股东大会（AGM），此次会议将以混合形式举行，允许股东亲自或在线参与。这种方式旨在提高可及性和参与度，使股东能够实时提问和投票，反映了公司对透明度和利益相关者参与的承诺。</p>
<p>关于 (AU:NAN) 股票的最新分析师评级为买入，目标价格为 4.90 澳元。要查看 Nanosonics Limited 股票的完整分析师预测列表，请参见 AU:NAN 股票预测页面。</p>
<p><strong>关于 Nanosonics Limited 的更多信息</strong></p>
<p>Nanosonics Limited 在医疗保健行业运营，专注于感染预防解决方案。该公司以其创新产品而闻名，特别是在超声探头消毒领域，致力于提高患者安全性并降低医疗环境中的感染风险。</p>
<p><strong>平均交易量：</strong> 768,532</p>
<p><strong>技术情绪信号：</strong> 强烈买入</p>
<p><strong>当前市值：</strong> 13.1 亿澳元</p>

<p>Nanosonics Limited (AU:NAN) 宣布其 2025 年年度股东大会将以混合形式举行，允许股东亲自或在线参与。此举旨在提高可及性和参与度，使实时提问和投票成为可能。AU:NAN 的最新分析师评级为买入，目标价格为 4.90 澳元。Nanosonics 专注于医疗保健中的感染预防解决方案，特别是超声探头消毒，目前市值为 13.1 亿澳元，平均交易量为 768,532</p>

<p>Nanosonics Limited ( (AU:NAN) ) has issued an update.</p>
<div class="lb-trans"><p>Nanosonics Limited ( (AU:NAN) ) 发布了更新。</p>
</div><p>Nanosonics Limited has announced its 2025 Annual General Meeting (AGM), which will be held as a hybrid event, allowing shareholders to participate either in person or online. This approach aims to increase accessibility and engagement, enabling shareholders to ask questions and vote in real time, reflecting the company’s commitment to transparency and stakeholder involvement.</p>
<div class="lb-trans"><p>Nanosonics Limited 宣布将于 2025 年召开年度股东大会（AGM），此次会议将以混合形式举行，允许股东亲自或在线参与。这种方式旨在提高可及性和参与度，使股东能够实时提问和投票，反映了公司对透明度和利益相关者参与的承诺。</p>
</div><p>The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.90 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.</p>
<div class="lb-trans"><p>关于 (AU:NAN) 股票的最新分析师评级为买入，目标价格为 4.90 澳元。要查看 Nanosonics Limited 股票的完整分析师预测列表，请参见 AU:NAN 股票预测页面。</p>
</div><p><strong>More about Nanosonics Limited</strong></p>
<div class="lb-trans"><p><strong>关于 Nanosonics Limited 的更多信息</strong></p>
</div><p>Nanosonics Limited operates in the healthcare industry, specializing in infection prevention solutions. The company is known for its innovative products, particularly in the area of ultrasound probe disinfection, and focuses on enhancing patient safety and reducing infection risks in medical settings.</p>
<div class="lb-trans"><p>Nanosonics Limited 在医疗保健行业运营，专注于感染预防解决方案。该公司以其创新产品而闻名，特别是在超声探头消毒领域，致力于提高患者安全性并降低医疗环境中的感染风险。</p>
</div><p><strong>Average Trading Volume:</strong> 768,532</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 768,532</p>
</div><p><strong>Technical Sentiment Signal:</strong> Strong Buy</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 强烈买入</p>
</div><p><strong>Current Market Cap:</strong> A$1.31B</p>
<div class="lb-trans"><p><strong>当前市值：</strong> 13.1 亿澳元</p>
</div>

Nanosonics Limited 宣布将于 2025 年举行混合形式的年度股东大会，以增强股东的参与度